Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Promino Nutritional Sciences Inc C.MUSL

Alternate Symbol(s):  MUSLF

Promino Nutritional Sciences Inc., formerly Element Nutritional Sciences Inc., is a research-driven Canadian nutraceutical company. The Company is specializing in the development of science-based products for the global consumer packaged goods market, with a portfolio focused specifically on muscle health. The Company's lead product, Rejuvenate, is a formulation that is clinically proven to assist in the building, rebuilding, restoration, and rejuvenation of natural muscle mass. Rejuvenate helps boost energy and strengthen the metabolism and immune system. The Company also offers Promino, an elite performance supplement for both professional and amateur athletes to accelerate muscle recovery, build strength and accelerate recovery from injury.


CSE:MUSL - Post by User

Post by StockHawk1on May 19, 2022 2:23pm
54 Views
Post# 34696011

$ELMT expected to make record rev

$ELMT expected to make record rev

Earlier this week Element Nutritional Sciences Inc. ($ELMT.c $ELNSF) reported preliminary financial results for Q1 2022 that shows the company is expected to make record revenue. 


$ELMT's Q122 revenue is expected to be between $2M-$2.3M representing a 521% YoY growth rate. Its gross margin is expected to be between 35% and 40%. 


Insiders say that $ELMT's growth is largely attributable to how the company significantly expanded its distribution footprint. 


After an overall green week, $ELMT is trading slightly down @ $0.245

MC is $23.661M


https://ca.finance.yahoo.com/news/element-nutritional-sciences-report-record-050000550.html

 
<< Previous
Bullboard Posts
Next >>